Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Today St. Kitts & Nevis.
November 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
December 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 |
January 2026
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
Press releases published on December 22, 2025
December 22, 2025
RxSight, Inc. Announces Chief Financial Officer Transition
Indeterminate
GlobeNewswire
December 22, 2025
Regeneron Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire
December 22, 2025
Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
Indeterminate
GlobeNewswire
December 22, 2025
Celularity Announces Closing of Financing Transactions
Indeterminate
GlobeNewswire
December 22, 2025
Vivos Inc Summarizes Progress in its Animal Therapy Division
Indeterminate
GlobeNewswire
December 22, 2025
Tevogen CEO Donates Shares to Support Education for Underprivileged Children
Indeterminate
GlobeNewswire
December 22, 2025
PracticeLink Supports the Next Generation of Clinicians with Fall 2025 First Practice Fund Scholarships
Indeterminate
GlobeNewswire
December 22, 2025
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel
Indeterminate
GlobeNewswire
December 22, 2025
OneMedNet CEO Aaron Green Issues Letter to Shareholders Highlighting 2025
Indeterminate
GlobeNewswire
December 22, 2025
CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire
December 22, 2025
Imviva Biotech Announces First Patient Dosed in Phase 1b/2 TENACITY-01 Trial of CTD402 CAR-T Cell Therapy
Indeterminate
GlobeNewswire